Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model.

by Howard I Scher, Kirk Solo, Jason Valant, Mary B Todd, Maneesha Mehra
Published 2015-01-01

Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer

by David Lu, Rachel Krupa, Melissa Harvey, Ryon P. Graf, Nicole Schreiber, Ethan Barnette, Emily Carbone, Adam Jendrisak, Audrey Gill, Sarah Orr, Howard I. Scher, Joseph Daniel Schonhoft
Published 2020-10-01

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

by Mayu O Frank, Julia Kaufman, Suyan Tian, Mayte Suárez-Fariñas, Salina Parveen, Nathalie E Blachère, Michael J Morris, Susan Slovin, Howard I Scher, Matthew L Albert, Robert B Darnell
Published 2010-09-01

Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

by Michael R. McDevitt, Daniel L. J. Thorek, Takeshi Hashimoto, Tatsuo Gondo, Darren R. Veach, Sai Kiran Sharma, Teja Muralidhar Kalidindi, Diane S. Abou, Philip A. Watson, Bradley J. Beattie, Oskar Vilhemsson Timmermand, Sven-Erik Strand, Jason S. Lewis, Peter T. Scardino, Howard I. Scher, Hans Lilja, Steven M. Larson, David Ulmert
Published 2018-04-01

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

by Dana W. Y. Tsui, Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won, Preethi Srinivasan, Kety Huberman, Fanli Meng, Xiaohong Jing, Juber Patel, Maysun Hasan, Ian Johnson, Erika Gedvilaite, Brian Houck-Loomis, Nicholas D. Socci, S. Duygu Selcuklu, Venkatraman E. Seshan, Hongxin Zhang, Debyani Chakravarty, Ahmet Zehir, Ryma Benayed, Maria Arcila, Marc Ladanyi, Samuel A. Funt, Darren R. Feldman, Bob T. Li, Pedram Razavi, Jonathan Rosenberg, Dean Bajorin, Gopa Iyer, Wassim Abida, Howard I. Scher, Dana Rathkopf, Agnes Viale, Michael F. Berger, David B. Solit
Published 2021-05-01